Advertisement
Singapore markets closed

  • Straits Times Index

    3,290.70
    +24.75 (+0.76%)
     

  • Nikkei

    38,229.11
    +155.13 (+0.41%)
     

  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     

  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     

  • Bitcoin USD

    60,974.95
    -1,937.71 (-3.08%)
     

  • CMC Crypto 200

    1,260.65
    -97.36 (-7.17%)
     

  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     

  • Dow

    39,512.84
    +125.08 (+0.32%)
     

  • Nasdaq

    16,340.87
    -5.40 (-0.03%)
     

  • Gold

    2,366.90
    +26.60 (+1.14%)
     

  • Crude Oil

    78.20
    -1.06 (-1.34%)
     

  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     

  • FTSE Bursa Malaysia

    1,600.67
    -0.55 (-0.03%)
     

  • Jakarta Composite Index

    7,088.79
    -34.81 (-0.49%)
     

  • PSE Index

    6,511.93
    -30.53 (-0.47%)
     

Why Alkermes Stock Is Sinking Today

Keith Speights, The Motley Fool
·2-min read
Why Alkermes Stock Is Sinking Today

Shares of Alkermes (NASDAQ: ALKS) were sinking 14.3% as of 11 a.m. EST on Tuesday. The decline came after the company announced on Monday that it had received notices of partial termination from Johnson & Johnson's (NYSE: JNJ) Janssen subsidiary related to license agreements for Alkermes' NanoCrystal technology. Partial termination of the two license agreements affects royalties that Alkermes receives from J&J for antipsychotic drugs Invega Sustenna and Invega Trinza.

Continue reading